Nandrolone decanoate; use in HIV-associated lipodystrophy syndrome: a pilot study.
Gold
J
J
Batterham
M
M
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000378:metabolism; D045930:Anabolic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008060:Lipodystrophy / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D009277:Nandrolone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077603:Nandrolone Decanoate; D010865:Pilot Projects
D045930:Anabolic Agents; D009277:Nandrolone; D000077603:Nandrolone Decanoate